Early selegiline therapy reduces levodopa dose requirement in Parkinson's disease
✍ Scribed by V. V. Myllylä; E. H. Heinonen; J. A. Vuorinen; O.I. Kilkku; K. A. Sotaniemi
- Book ID
- 114784363
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 493 KB
- Volume
- 91
- Category
- Article
- ISSN
- 0001-6314
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract To further characterize the short‐term levodopa response in early PD, we performed a retrospective analysis of the ELLDOPA study which randomized 361 early PD subjects to placebo, levodopa 150, 300, or 600 mg/day. We evaluated change in UPDRS motor scores (UPDRSm) from baseline to weeks
## Abstract The use of early combination therapy with bromocriptine (Br) and levodopa (LD) in Parkinson's disease is controversial. It has been suggested that treatment with this regimen would prevent or delay the onset of motor fluctuations and dyskinesia. Thus, some have recommended it as a stand